DM
David R. McAvoy
EVP, Chief Legal Officer

David R. McAvoy insider trades: Teva Pharmaceutical Industries (TEVA) stock buys and sales

EVP, Chief Legal Officer, Teva Pharmaceutical Industries Last trade Sep 5, 2025 16 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2020
4
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 5, 2025TEVA↑ Buy$21K
Mar 5, 2025TEVA↓ Sell$76K
Jul 23, 2021BBI↑ Buy$12K
May 17, 2021BBI↑ Buy$15K
May 17, 2021BBI↑ Buy$6K
Sep 18, 2020BBI↑ Buy$14K
Sep 18, 2020BBI↑ Buy$5K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TEVA insiders

Open-market trades in the last 12 months

About David R. McAvoy's insider trades

David R. McAvoy is EVP, Chief Legal Officer at Teva Pharmaceutical Industries (TEVA). Since Sep 18, 2020, David has reported 6 open-market purchases worth $73K and 1 sale worth $76K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (7 filings), option exercises (3 filings), shares withheld for taxes (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TEVA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.